Grant Opportunities in Immunology and Microbiology
Bridging Research and Resources for Tomorrow's Discoveries
Multiplex Platforms to Assess Indicators of Micronutrient Status, Inflammation and Infectious Disease
The Bill & Melinda Gates Foundation offers awards to develop multiplex platforms for assessing micronutrient status, inflammation, and infectious disease in target populations.
Published At
Interventional Research Studies of Brentuximab Vedotin-Based Novel Combinations in AITL and PTCL-NOS
Pfizer Inc. offers research grants for interventional studies exploring novel brentuximab vedotin combinations in AITL and PTCL-NOS for US-based investigators.
Published At
Improving the Quality and Standardization of Pneumococcal Diagnostic Pathways in Pediatric and Adult Populations
Pfizer LLC offers grants up to EUR 50,000 to Italian institutions to improve the quality and standardization of pneumococcal diagnostic pathways in pediatric and adult populations.
Published At
Development of Healthcare Professionals with Advanced Expertise in Preventive Strategies in Pediatric Infectious Diseases
Pfizer International LLC offers grants to healthcare professionals in Japan to advance preventive strategies and expertise in pediatric infectious diseases.
Published At
Improving the Vaccination Environment to Prevent Respiratory Infectious Diseases in Older Adults and High-Risk Individuals
Pfizer International LLC offers grants to healthcare organizations in Japan to improve vaccination environments for respiratory diseases in older adults and high-risk individuals.
Published At
Innovations in Decentralized Pan-Orthoebolavirus Diagnostics
The Gates Foundation invites research institutes and companies to develop field-ready, decentralized pan-Orthoebolavirus diagnostics to combat Ebola outbreaks.
Published At
Advancing Adult Immunization Strategies: A Focus on the Impact of Respiratory Syncytial Virus (RSV) and Cardiorespiratory Outcomes
Pfizer Inc. offers grants up to $200,000 for medical education initiatives focused on the impact of RSV infection and cardiorespiratory outcomes in high-risk adults.
Published At
Call for Centre for Advanced Research (CAR)-2026, under Extramural Research Program
ICMR's CAR-2026 program provides research grants of INR 8-15 crores to experienced teams for decisive research solving critical public health problems in India.
Published At
OPTIMA-HEMA Project: Optimizing the Management and Application of Novel Immunotherapies in Hematologic Malignancies
Pfizer offers quality improvement grants for healthcare institutions in Mainland China to optimize immunotherapy management for Multiple Myeloma and B-cell ALL patients.
Published At
MRFF 2026 National Critical Research Infrastructure
The Department of Health, Disability and Ageing offers $85M for the 2026 National Critical Research Infrastructure to support Australian medical research innovation.
Published At